IP Library Granted Patent US 11,786,501
Granted Patent B2
US 11,786,501 · App. 17/694,500 · Granted Oct 17, 2023

Nitroxyl donors with improved therapeutic index

Inventors: Vincent Jacob Kalish (Annapolis, MD); Frederick Arthur Brookfield (Abingdon, GB); Stephen Martin Courtney (Abingdon, GB); Lisa Marie Frost (Abingdon, GB); John P. Toscano (Glen Arm, MD)
Assignee: Cardioxyl Pharmaceuticals, Inc.
A61K31/341A61K9/0019A61K9/08A61K31/18A61K31/222A61K31/24A61K31/255A61K31/343A61K31/381A61K31/404A61K31/42A61K31/433A61K31/4436A61K31/538A61K31/5377A61K47/12A61K47/40A61P9/04C07C317/14C07D307/64
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,786,501
App. No.
17/694,500
Granted
Oct 17, 2023
Kind
B2
Abstract

The disclosed subject matter provides N-substituted hydroxylamine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the disclosed subject matter provides methods of using such compounds or pharmaceutical compositions for treating heart failure.

Claims (11)

1. A method of treating ischemia/reperfusion injury, comprising administering an effective amount of a compound of formula (1), or a pharmaceutical composition comprising the compound of formula (1), to a patient in need thereof, wherein the compound of formula (1) is represented by formula:

2. The method of claim 1 , wherein the compound or the pharmaceutical composition is administered intravenously.

3. The method of claim 2 , wherein the compound or the pharmaceutical composition is administered in an amount of at least 1 ug/kg/min.

4. The method of claim 2 , wherein the compound or the pharmaceutical composition is administered in an amount of at least 2.5 ug/kg/min.

5. The method of claim 2 , wherein the compound or the pharmaceutical composition is administered in an amount of at least 5 ug/kg/min.

6. The method of claim 2 , wherein the compound or the pharmaceutical composition is administered in an amount of at least 7.5 ug/kg/min.

7. The method of claim 2 , wherein the compound or the pharmaceutical composition is administered in an amount of at least 12 ug/kg/min.

8. The method of claim 2 , wherein the compound or the pharmaceutical composition is administered in an amount of at least 15 ug/kg/min.

9. The method of claim 2 , wherein the compound or the pharmaceutical composition is administered in an amount of no more than about 30 ug/kg/min.

10. The method of claim 2 , wherein the compound or the pharmaceutical composition is administered in an amount of from about 1 ug/kg/min to about 100 ug/kg/min.

11. The method of claim 2 , wherein the compound or the pharmaceutical composition is administered in an amount of from about 2.5 ug/kg/min to about 100 ug/kg/min.

Continuity (11)
Continuation 17063372 · Oct 5, 2020
Continuation 16724657 · Dec 23, 2019
Continuation 16242139 · Jan 8, 2019
Continuation 15960993 · Apr 24, 2018
Continuation 15430946 · Feb 13, 2017
Continuation 14880173 · Oct 9, 2015
Continuation 14641377 · Mar 7, 2015
Continuation 14158456 · Jan 17, 2014
Provisional Application 61782781 · Mar 14, 2013
Provisional Application 61754237 · Jan 18, 2013
Related Publication 20220193026A1 · Jun 23, 2022
Cited By (1)
US 12,186,301